Fontenay aux Roses, France

Régine Bartsch-Li


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Régine Bartsch-Li

Introduction

Régine Bartsch-Li is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological conditions. His work is characterized by a focus on therapeutic applications that can improve patient outcomes.

Latest Patents

Régine Bartsch-Li holds a patent for "4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use." This patent describes derivatives that have an affinity for peripheral benzodiazepine receptors. These compounds are useful for the prevention or treatment of peripheral neuropathies and for addressing central neurodegenerative diseases. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Throughout his career, Régine Bartsch-Li has been associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmacology.

Collaborations

Régine Bartsch-Li has worked alongside notable colleagues such as Frank Marguet and Jacques Froissant. These collaborations have enriched his research and expanded the impact of his inventions in the pharmaceutical industry.

Conclusion

Régine Bartsch-Li's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve the quality of life for patients suffering from neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…